Episode Details
Back to Episodes342: FDA cuts, zombie biotechs, and too much weight loss?
Published 1 year, 8 months ago
Description
Mizuho analyst Jared Holz joins to discuss Adam's column on biotech's dark period. We also talk about Elaine's latest article on the push for greater and greater weight loss from obesity drugs, along with developments at Solid Biosciences and federal job cuts.